Biotricity, Inc. (BTCY)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 5.94 Million USD | -8.72% |
| 2023 | 6.51 Million USD | -60.96% |
| 2022 | 16.67 Million USD | 275.8% |
| 2021 | 4.43 Million USD | 121.41% |
| 2020 | 2 Million USD | 308.51% |
| 2019 | 490.66 Thousand USD | -47.21% |
| 2018 | 929.42 Thousand USD | 96.28% |
| 2017 | 473.51 Thousand USD | -8.78% |
| 2016 | 519.09 Thousand USD | 2668.8% |
| 2015 | 18.74 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 5.94 Million USD | 8.32% |
| 2024 Q1 | 6.14 Million USD | -5.63% |
| 2024 FY | 5.94 Million USD | -8.72% |
| 2024 Q3 | 5.48 Million USD | -19.6% |
| 2024 Q2 | 6.82 Million USD | 11.06% |
| 2023 Q2 | 8.05 Million USD | -33.72% |
| 2023 FY | 6.51 Million USD | -60.96% |
| 2023 Q4 | 6.51 Million USD | -2.05% |
| 2023 Q3 | 6.64 Million USD | -17.46% |
| 2023 Q1 | 12.14 Million USD | -27.15% |
| 2022 Q4 | 16.67 Million USD | -20.75% |
| 2022 FY | 16.67 Million USD | 275.8% |
| 2022 Q3 | 21.04 Million USD | 50.84% |
| 2022 Q2 | 13.95 Million USD | 404.19% |
| 2022 Q1 | 2.76 Million USD | -37.65% |
| 2021 FY | 4.43 Million USD | 121.41% |
| 2021 Q1 | 1.38 Million USD | -30.7% |
| 2021 Q3 | 5.13 Million USD | 148.57% |
| 2021 Q4 | 4.43 Million USD | -13.65% |
| 2021 Q2 | 2.06 Million USD | 48.85% |
| 2020 Q3 | 5.52 Million USD | 422.75% |
| 2020 Q1 | 1.04 Million USD | 113.37% |
| 2020 Q4 | 2 Million USD | -63.75% |
| 2020 FY | 2 Million USD | 308.51% |
| 2020 Q2 | 1.05 Million USD | 1.03% |
| 2019 FY | 490.66 Thousand USD | -47.21% |
| 2019 Q2 | 419.42 Thousand USD | 46.33% |
| 2019 Q1 | 286.63 Thousand USD | -69.16% |
| 2019 Q4 | 490.66 Thousand USD | 3.71% |
| 2019 Q3 | 473.09 Thousand USD | 12.8% |
| 2018 Q2 | 667.41 Thousand USD | -46.26% |
| 2018 FY | 929.42 Thousand USD | 96.28% |
| 2018 Q4 | 929.42 Thousand USD | -63.88% |
| 2018 Q3 | 2.57 Million USD | 285.51% |
| 2018 Q1 | 1.24 Million USD | 162.26% |
| 2017 FY | 473.51 Thousand USD | -8.78% |
| 2017 Q1 | 109.67 Thousand USD | -31.23% |
| 2017 Q2 | 84.05 Thousand USD | -23.36% |
| 2017 Q3 | 67.51 Thousand USD | -19.68% |
| 2017 Q4 | 473.51 Thousand USD | 601.35% |
| 2016 Q1 | 28 Thousand USD | 0.0% |
| 2016 Q2 | 18.74 Thousand USD | -33.04% |
| 2016 Q3 | 519.09 Thousand USD | 2668.8% |
| 2016 Q4 | 159.48 Thousand USD | -69.28% |
| 2016 FY | 519.09 Thousand USD | 2668.8% |
| 2015 FY | 18.74 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 81.054% |
| BrainsWay Ltd. | 62.97 Million USD | 90.563% |
| Cerus Corporation | 197.74 Million USD | 96.995% |
| Envoy Medical, Inc. | 7.64 Million USD | 22.217% |
| electroCore, Inc. | 16.38 Million USD | 63.736% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 22.743% |
| IceCure Medical Ltd | 16.41 Million USD | 63.787% |
| Inogen, Inc. | 326.19 Million USD | 98.178% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.678% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 78.208% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 64.156% |
| MaxCyte, Inc. | 268.27 Million USD | 97.785% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 26.61% |
| Nexalin Technology, Inc. | 3.63 Million USD | -63.622% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.358% |
| PAVmed Inc | 33.11 Million USD | 82.057% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 95.857% |
| RxSight, Inc. | 182.55 Million USD | 96.745% |
| Sight Sciences, Inc. | 166.65 Million USD | 96.434% |
| SI-BONE, Inc. | 230.42 Million USD | 97.421% |
| TELA Bio, Inc. | 78.04 Million USD | 92.386% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 97.641% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 44.617% |
| Acutus Medical, Inc. | 53.96 Million USD | 88.987% |
| Talis Biomedical Corporation | 98.34 Million USD | 93.957% |
| Spectral AI, Inc. | 10.69 Million USD | 44.42% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 97.282% |
| CVRx, Inc. | 115.22 Million USD | 94.843% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 89.87% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -90.759% |
| Bioventus Inc. | 810.91 Million USD | 99.267% |
| Venus Concept Inc. | 93.65 Million USD | 93.655% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 76.899% |
| LivaNova PLC | 2.42 Billion USD | 99.755% |
| 908 Devices Inc. | 202.98 Million USD | 97.072% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.262% |
| Nemaura Medical Inc. | 14.56 Million USD | 59.194% |
| NeuroPace, Inc. | 107.65 Million USD | 94.48% |
| LENSAR, Inc. | 69.58 Million USD | 91.46% |
| Apyx Medical Corporation | 79.24 Million USD | 92.5% |
| Cutera, Inc. | 346.29 Million USD | 98.284% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 85.856% |
| BioSig Technologies, Inc. | 1.79 Million USD | -230.513% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 97.804% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 86.07% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.843% |
| Axonics, Inc. | 719.92 Million USD | 99.175% |
| Outset Medical, Inc. | 313.8 Million USD | 98.106% |
| IRIDEX Corporation | 34.43 Million USD | 82.743% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 98.532% |
| IRadimed Corporation | 92.15 Million USD | 93.552% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -13.107% |
| INVO Bioscience, Inc. | 20.88 Million USD | 71.55% |
| Telesis Bio, Inc. | 70.41 Million USD | 91.56% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 96.144% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.524% |
| Quipt Home Medical Corp. | 247.4 Million USD | 97.598% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 36.169% |
| Pulmonx Corporation | 178.95 Million USD | 96.679% |
| Dynatronics Corporation | 25.94 Million USD | 77.091% |
| Modular Medical, Inc. | 13.8 Million USD | 56.959% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 44.601% |
| Semler Scientific, Inc. | 78.06 Million USD | 92.388% |
| InMode Ltd. | 863.28 Million USD | 99.312% |
| Bruker Corporation | 4.24 Billion USD | 99.86% |
| Cytosorbents Corporation | 53.26 Million USD | 88.842% |
| DexCom, Inc. | 6.26 Billion USD | 99.905% |
| Align Technology, Inc. | 6.08 Billion USD | 99.902% |
| Viveve Medical, Inc. | 25.91 Million USD | 77.067% |
| ZimVie Inc. | 1.2 Billion USD | 99.507% |
| Movano Inc. | 9.42 Million USD | 36.922% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.806% |
| Nexalin Technology, Inc. | 3.63 Million USD | -63.622% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 89.87% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.376% |
| Profound Medical Corp. | 43.68 Million USD | 86.397% |
| Insulet Corporation | 2.58 Billion USD | 99.77% |
| enVVeno Medical Corporation | 48.63 Million USD | 87.781% |
| Surmodics, Inc. | 185.73 Million USD | 96.8% |
| iCAD, Inc. | 41.41 Million USD | 85.652% |
| Nuwellis, Inc. | 9.77 Million USD | 39.175% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.628% |
| Aethlon Medical, Inc. | 8.24 Million USD | 27.933% |
| InspireMD, Inc. | 47.64 Million USD | 87.527% |
| PAVmed Inc. | 33.11 Million USD | 82.057% |
| BIOLASE, Inc. | 35.1 Million USD | 83.07% |
| Beyond Air, Inc. | 56.96 Million USD | 89.567% |
| FONAR Corporation | 214.24 Million USD | 97.226% |
| AxoGen, Inc. | 196.82 Million USD | 96.981% |
| Vivani Medical, Inc. | 45.79 Million USD | 87.024% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 97.888% |
| Inari Medical, Inc. | 674.23 Million USD | 99.119% |
| UFP Technologies, Inc. | 404.13 Million USD | 98.53% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 74.603% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 37.467% |
| Tenon Medical, Inc. | 6.34 Million USD | 6.342% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 36.828% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 94.267% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.871% |
| Sintx Technologies, Inc. | 15.36 Million USD | 61.324% |
| NanoVibronix, Inc. | 6.67 Million USD | 10.959% |
| Quanterix Corporation | 425.01 Million USD | 98.602% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 36.169% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 88.939% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.66% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.158% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 90.596% |
| NeuroMetrix, Inc. | 21.42 Million USD | 72.262% |
| Hyperfine, Inc. | 94.19 Million USD | 93.691% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 97.788% |
| Biomerica, Inc. | 9.25 Million USD | 35.783% |
| Bone Biologics Corporation | 3.73 Million USD | -58.989% |
| AVITA Medical, Inc. | 144.33 Million USD | 95.883% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -22.062% |
| Silk Road Medical, Inc | 265.3 Million USD | 97.76% |